- Home
- BODI vs DYAI Comparison
BODI vs DYAI Comparison
Compare BODI & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- DYAI
- Stock Information
- Founded
- BODI 1998
- DYAI 1979
- Country
- BODI United States
- DYAI United States
- Employees
- BODI N/A
- DYAI N/A
- Industry
- BODI Industrial Machinery/Components
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BODI Industrials
- DYAI Health Care
- Exchange
- BODI Nasdaq
- DYAI Nasdaq
- Market Cap
- BODI 25.4M
- DYAI 28.3M
- IPO Year
- BODI N/A
- DYAI 2004
- Fundamental
- Price
- BODI $3.97
- DYAI $0.98
- Analyst Decision
- BODI Strong Buy
- DYAI Strong Buy
- Analyst Count
- BODI 3
- DYAI 1
- Target Price
- BODI $10.67
- DYAI $6.00
- AVG Volume (30 Days)
- BODI 20.0K
- DYAI 64.2K
- Earning Date
- BODI 08-05-2025
- DYAI 08-12-2025
- Dividend Yield
- BODI N/A
- DYAI N/A
- EPS Growth
- BODI N/A
- DYAI N/A
- EPS
- BODI N/A
- DYAI N/A
- Revenue
- BODI $371,113,000.00
- DYAI $3,554,344.00
- Revenue This Year
- BODI N/A
- DYAI $22.56
- Revenue Next Year
- BODI N/A
- DYAI $30.95
- P/E Ratio
- BODI N/A
- DYAI N/A
- Revenue Growth
- BODI N/A
- DYAI 57.59
- 52 Week Low
- BODI $3.38
- DYAI $0.91
- 52 Week High
- BODI $8.71
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- BODI 49.25
- DYAI 49.96
- Support Level
- BODI $3.81
- DYAI $0.91
- Resistance Level
- BODI $4.43
- DYAI $1.02
- Average True Range (ATR)
- BODI 0.27
- DYAI 0.05
- MACD
- BODI 0.02
- DYAI 0.01
- Stochastic Oscillator
- BODI 44.58
- DYAI 46.80
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.